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Abstract
Background: Suboptimal specimen processing and storage conditions of samples which contain
hepatitis C virus (HCV) RNA may result in a decline of HCV RNA concentration or false-negative
results in the detection of HCV RNA in serum. We evaluated the stability of HCV RNA in serum
and clotted blood samples stored at room temperature or at 4C for 4 days with the aim of
optimizing the standard procedures of processing and storage of samples.
Methods: Blood from five HCV RNA positive patients was collected in tubes with and without
separator gel, centrifuged 1 or 6 hours after collection. Samples were then left 6, 24, 48, 72 or 96
h at room temperature (21.5 – 25.4C) or at 4C before determining their HCV RNA level using
the COBAS AMPLICOR HCV MONITOR Test, vs 2.0 (Roche Diagnostic Systems).
Results: The logarithm of the HCV RNA level measurements remained within a 0.3 value of the
means for 4 days at both temperatures (room temperature or 4C).
Conclusions: We conclude that blood samples may be collected and aliquoted within 6 h of
collection and can be stored at 4C for 72 hours as proposed by the manufacturer without
significant differences in measured HCV RNA level. Our results indicate that lapses in this scheme
may still yield reliable results.
Background
Both hepatitis C virus (HCV) RNA viral load and HCV
genotype have been described as important for predicting
the response to anti-HCV therapy. Quantification of HCV
RNA in serum is used to predict treatment response and to
monitor antiviral therapy. Suboptimal specimen process-
ing and storage conditions among other factors (e.g. oper-
ator problems, reagent lot variability, etc.) may cause
false-negative results in HCV RNA detection or underesti-
mate HCV RNA load values. Since serum specimens are
often transported to central laboratories for HCV RNA lev-
el determination, it was important to define conditions
that preserve HCV RNA integrity. The aim of this study
was to evaluate the stability of HCV RNA in serum and in
clotted blood at room temperature and at 4C for 4 days
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in order to optimize the standard procedures of process-
ing and storage.
Methods
We collected blood by venipuncture from five HCV RNA
positive patients (2 female and 3 male; ages from 40 to 67
years) at time 0 after informed consent. All sampling and
testing were done in accordance with ethical standards in
Belgium and according to the guidelines of the 1975 Dec-
laration of Helsinki. From each patient, three blood sam-
ples were collected in 7 ml-tubes with separator and two
blood samples in 7 ml-tubes without separator (Sarstedt,
Nombrecht, Germany). The tubes with separator contain
a gel barrier to enable immediate separation of serum
from the clot following a single centrifugation step (dur-
ing 10 minutes at 3000 rpm). Two tubes with separator
and the two tubes without separator were centrifuged at
3000 rpm during 10 minutes within the hour of collection
(Table 1).
One aliquot (170 l) of the serum from the tubes without
separator was transfered in a microtube as reference for ti-
tre determination at time-point 0 and immediately frozen
at -80C until testing. After centrifugation, one tube with-
out separator was kept at 4C and the other tube without
separator at room temperature during 6, 24, 48, 72 and 96
hours before freezing an aliquot at -80C. This procedure
allowed contact between serum and clot over these  re-
spective times. Room temperature was checked with a dig-
ital maximum/minimum thermometer and found to be
between 21.5C and 25.4C over the study period.
After this centrifugation, the serum of two tubes with sep-
arator was aliquoted in 11 dry microtubes (170 l each).
One microtube was used as a reference for titre determina-
tion at time-point 0 (reference) and was immediately
stored at -80C until testing. Five dry microtubes were
stored at 4C and five dry microtubes were stored at room
temperature during 6, 24, 48, 72 and 96 hours respective-
ly before being frozen at -80C.
The third tube with separator was kept at room tempera-
ture (21.5C – 25.4C) during 6 hours before being cen-
trifuged at 3000 rpm during 10 minutes and the serum
was aliquoted (170 l each) in 9 dry microtubes. One mi-
crotube was used as reference for titre determination at 6
hours and was stored at -80C until testing. The 8 other
microtubes were kept during 24, 48, 72 and 96 hours be-
fore being frozen at -80C : 4 microtubes at 4C and 4 mi-
crotubes at room temperature. On the serum of each
Table 1: Serum tube handling before testing
Tube 1 without
 separator =>
centrifuge within 
1 hour =>
1 aliquot (time 0) at -80C => tube kept at 4C => aliquots at -80C at 6 hours
at 24 hours
at 48 hours
at 72 hours
at 96 hours
Tube 2 without 
separator =>
centrifuge within 
1 hour =>
tube kept at room t => aliquots at -80C at 6 hours
at 24 hours
at 48 hours
at 72 hours
at 96 hours
Tube 3 with
 separator =>
centrifuge within 
1 hour =>
make 6 aliquots and keep one 
(time 0) 
at -80C =>
aliquots kept at 4C => aliquots at -80C at 6 hours
at 24 hours
at 48 hours
at 72 hours
at 96 hours
Tube 4 with
 separator =>
centrifuge within
 1 hour =>
make 5 aliquots => aliquots at room t => aliquots at -80C at 6 hours
at 24 hours
at 48 hours
at 72 hours
at 96 hours
Tube 5 with
 separator =>
at room t for 6 hours 
then centrifuged =>
make 9 aliquots and 
keep 1 aliquot (6 h) at -80C =>
4 aliquots at 4C => aliquots at -80C at 24 hours
at 48 hours
at 72 hours
at 96 hours
4 aliquots at room t aliquots at -80C at 24 hours
at 48 hours
at 72 hours
at 96 hoursBMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/22
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reference microtube, a qualitative nested RT-PCR was per-
formed to confirm the presence of HCV RNA in each sam-
ple. After this confirmation, a quantitative RT-PCR was
performed to determine the HCV RNA load, using an au-
tomated commercial method: COBAS AMPLICOR HCV
MONITOR Test, version 2.0 (Roche Diagnostic Systems
Inc., Branchburg, NJ, USA). This quantitative RT-PCR was
also performed on each microtube frozen at -80C. All the
reference samples (at time-point 0) were positive for the
qualitative nested RT-PCR and the quantitative RT-PCR in
the 5 patients included in this study. To minimize the ef-
fect of analytical variability all samples from the same pa-
tient were tested in the same analytical series. A high and
a low positive control were tested in each test run. RNA ex-
traction and RT-PCR were performed according to the
manufacturer's instructions. The results are expressed in
international units (IU) per milliliter. Statistical analysis
and data transformations (log transformation, SD and SE,
comparison of means, confidence intervals, coefficient of
variation, percentile distribution) were performed with
the PRISM Software Version 2.0 (GraphPad, San Diego,
CA, USA). A difference was considered significant if the p-
value was lower than 0.05.
Results
All the samples stored at room temperature or stored at
4C for 6, 24, 48, 72, and 96 hours were positive for the
quantitative RT-PCR. The mean viral load was 362,000
IU/ml (5.544 log;SD = 0.023) for patient 1; 680,940 IU/
ml (5.818 log; SD = 0.063) for patient 2; 73,690 IU/ml
(4.862 log; SD = 0.028) for patient 3; 134,630 IU: ml
(5.119 log; SD = 0.097) for patient 4 and 981,870 ml
(5.977 log; SD = 0.034) for patient 5. All the values of the
positive controls in each of the 10 analytical series were
between the expected lower and the upper limits. The
mean viral load for the high positive control was 74,900
IU/ml (4.87 log; SD = 0.064) with an interrun coefficient
of variation (CV) of 14.9%. For the low positive control,
the mean was 5,838 IU/ml (3.751 log; SD=O.122) with
an interrun CV of 27.3%. Figures 1 to 5 show, for each pa-
tient, the values of viral load measurements in IU/ml on
the different samples at each time point on a logarithmic
scale. Mean values of measurements are given with a thick
line. Mean values did not change much over time. The CV
of measurements on different samples in a same patient at
different time points varied between 0.16% and 27.9% at
time 0, 19.2% and 27.5% at 6 hours, 13.7% and 40.0% at
24 hours, 7% and 33.3% at 48 hours, 16.1% and 32.3%
at 72 hours and 12.2% and 33.4% at 96 hours. The loga-
rithm of the viral load measurements on each sample re-
Figure 1
Viral load measurements over time in patient 1 in IU/ml on a
log scale. SS-TA: tube without serum separator at room tem-
perature; SS-4C: tube with serum separator at 4 C; AS-1H-
TA: tube with separator, centrifuged within the first hour and
kept at room temperature; AS-1H-4C: tube with separator,
centrifuged within the first hour and kept at 4C; AS-6H-TA:
tube with separator, centrifuged after 6 hours and kept at
room temperature; AS-6H-4C: tube with separator, centri-
fuged after 6 hours and kept at 4C. The mean of measure-
ments at each point of time is given in open triangles linked
by a thick line.
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Figure 2
Viral load measurements over time in patient 2 in IU/ml on a
log scale. SS-TA: tube without serum separator at room tem-
perature; SS-4C: tube with serum separator at 4C; AS-1H-
TA: tube with separator, centrifuged within the first hour and
kept at room temperature; AS-1H-4C: tube with separator,
centrifuged within the first hour and kept at 4C; AS-6H-TA:
tube with separator, centrifuged after 6 hours and kept at
room temperature; AS-6H-4C: tube with separator, centri-
fuged after 6 hours and kept at 4C. The mean of measure-
ments at each point of time is given in open triangles linked
by a thick line.
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mained at any time within 0.3 of the mean. No significant
difference was observed for any single patient between the
viral load obtained from different kinds of tubes (with or
without separator), after different times of centrifugation
and separation (1 hour or 6 hours after collection) or with
different storage conditions (at room temperature or re-
frigerated at 4C) for variable periods of time.
Discussion
Both hepatitis C virus (HCV) RNA viral load and HCV
genotype have been described as important for predicting
the response to anti-HCV therapy. Suboptimal storage
temperatures may affect HCV RNA stability and influence
viral load measurements.
There was one outlier value in patient 2 after 24 hours of
storage at room temperature (tube with separator, whose
serum was separated from erythrocytes within 1 hour
post-collection). This isolated discordance was not found
with the other samples of the same patient at any other
time point. This discordant value certainly points to an
analytical error. It explains a higher CV at 24 hours. In the
literature there are still controversies regarding the stabili-
ty of HCV RNA under different processing and storage
conditions. Several studies have shown that HCV RNA is
unstable in serum after storage at room temperature [1–
3]. Some reports have claimed that HCV RNA in separated
serum is stable for at least 4 days at 4C but that concen-
trations decrease with increasing temperature [5] or that
RNA is stable for at least 3 days at both room temperature
and 4C [6]. Other reports showed that the concentration
of HCV RNA remained stable in serum specimens subject-
ed to three to eight freeze-thaw cycles [7,8]. Results may
differ according to type of collection tube. Wang et al. re-
ported already 10 years ago that serum or citrated plasma
specimens are satisfactory for detecting HCV RNA by PCR,
but that heparinized blood specimens are not [9]. Mis-
kowsky et al.[10] and Damen et al.[11] demonstrated that
plasma tubes (EDTA or ACD) or serotubes are suitable to
measure HCV RNA concentrations. For Grant et al.[12]
whole blood anticoagulated with EDTA or CPDA-1/EDTA
may be stored at up to 25C for 5 days without any signif-
icant loss in plasma HCV RNA level. Kessler et al. conclud-
ed that HCV RNA remains stable in NASTs (tubes which
contain a liquid nucleic acid stabilizer) at room tempera-
ture for at least 96 h, whereas a significant increase of HCV
RNA was observed in two different types of EDTA tubes
[13].
These different studies use different blood collection
tubes and different processing times and are therefore not
Figure 3
Viral load measurements over time in patient 3 in IU/ml on a
log scale. SS-TA: tube without serum separator at room tem-
perature; SS-4C: tube with serum separator at 4C; AS-1H-
TA: tube with separator, centrifuged within the first hour and
kept at room temperature; AS-1H-4C: tube with separator,
centrifuged within the first hour and kept at 4C; AS-6H-TA:
tube with separator, centrifuged after 6 hours and kept at
room temperature; AS-6H-4C: tube with separator, centri-
fuged after 6 hours and kept at 4C. The mean of measure-
ments at each point of time is given in open triangles linked
by a thick line.
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Figure 4
Viral load measurements over time in patient 4 in IU/ml on a
log scale. SS-TA: tube without serum separator at room tem-
perature; SS-4C: tube with serum separator at 4C; AS-1H-
TA: tube with separator, centrifuged within the first hour and
kept at room temperature; AS-1H-4C: tube with separator,
centrifuged within the first hour and kept at 4C; AS-6H-TA:
tube with separator, centrifuged after 6 hours and kept at
room temperature; AS-6H-4C: tube with separator, centri-
fuged after 6 hours and kept at 4C. The mean of measure-
ments at each point of time is given in open triangles linked
by a thick line.
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really comparable. The general picture is that HCV viral
RNA is more stable than generally thought before. In our
laboratory we used to accept only serum, which had been
centrifuged and separated within 1 h of collection, frozen
at -70C to -80C if stored and transported frozen to our
laboratory for the measurement of HCV RNA. To allow
less strict procedures we evaluated the effects on the HCV
RNA stability of two types of blood collection tubes (dry
tubes with separator and without separator), three
processing times (centrifugation within 1 h after collec-
tion without separation of serum from the clot, centrifu-
gation within 1 h followed by separation and
centrifugation 6 h later), two storage temperatures (at
+4C and at room temperature) and five storage times (6,
24, 48, 72 and 96 h). We chose to compare only serum
specimens because in different reports only slight differ-
ences are found between serum and plasma. Moreover se-
rum samples are usually used for other viral serological
parameters. The two temperatures analysed in our study
are the most frequent storage and transport temperatures
for blood samples. We compared the HCV RNA levels dur-
ing 4 days of storage because it is a common duration to
which we are confronted with samples coming from other
centres. No significant differences were observed in any
patient between the viral loads from different kinds of se-
rum tubes, with different processing and storage condi-
tions. This relatively long stability of HCV RNA may be
explained by the particulate nature of this RNA, i.e. the
fact that it is essentially enclosed in viral particles.
Our results validate the procedure proposed by the man-
ufacturer, i.e. that blood samples must be collected and al-
iquoted within 6 h of collection and may be stored at 4C
for as long as 72 hours. Furthermore our results indicate
that lapses in this scheme may still yield correct results.
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